Extramedullary plasmacytoma immunoglobulin D (lambda) in the chest wall and the subglottic region.
Sakiyama
Shoji
S
Department of Oncological Surgery, Graduate School of Medicine, University of Tokushima, Kuramoto-cho 3, Tokushima 770-8503, Japan. sakiyama@clin.med.tokushima-u.ac.jp
Kondo
Kazuya
K
Mitsuteru
Yoshida
Y
Takizawa
Hiromitsu
H
Kenzaki
Koichiro
K
Miyoshi
Takanori
T
Abe
Masahiro
M
Wakatsuki
Shingo
S
Monden
Yasumasa
Y
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001706:Biopsy; D003907:Dexamethasone / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D005931:Glottis; D006801:Humans; D007072:Immunoglobulin D; D019394:Ki-67 Antigen; D007822:Laryngeal Neoplasms / Q000175:diagnosis* / Q000188:drug therapy; D008279:Magnetic Resonance Imaging; D008875:Middle Aged; D016609:Neoplasms, Second Primary / Q000175:diagnosis* / Q000628:therapy; D010954:Plasmacytoma / Q000175:diagnosis* / Q000628:therapy; D011379:Prognosis; D018714:Radiotherapy, Adjuvant; D035583:Rare Diseases; D012075:Remission, Spontaneous; D013899:Thoracic Neoplasms / Q000175:diagnosis* / Q000601:surgery; D035441:Thoracic Wall; D014057:Tomography, X-Ray Computed; D014750:Vincristine / Q000008:administration & dosage
D007072:Immunoglobulin D; D019394:Ki-67 Antigen; D014750:Vincristine; D003907:Dexamethasone; D004317:Doxorubicin